November 17, 2017 8:48 PM ET

Biotechnology

Company Overview of Valbiotis SA

Key Executives for Valbiotis SA

NameBoard RelationshipsTitleAge
Sébastien Peltier Ph.D., HDRNo RelationshipsChief Executive Officer39
Jocelyn Pineau M.D.No RelationshipsAdministration and Finance Director--
Philippe Sibour No RelationshipsChief Executive Officer of Alliance Consulting--
Pascal Sirvent 11 RelationshipsDirector of Discovery & Preclinical Research and Member of Scientific & Medical Board--
Philippe Charier M.D.No RelationshipsBusiness Development and Marketing Director46

Valbiotis SA Board Members*

NameBoard RelationshipsPrimary CompanyAge
Laurent Levy Ph.D. 11 RelationshipsNanobiotix SA44
Pascal Sirvent 11 RelationshipsValbiotis SA--
Philippe Vuagnat Ph.D. 13 RelationshipsEmergence Innovation I, FPCI64
Sébastien Bessy 11 RelationshipsValbiotis SA--
Nathalie Boisseau 11 RelationshipsValbiotis SA--
View All Board Members

Valbiotis SA Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Supervisory Board Ph.D.Laurent Levy11 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
389.6K
Bonus
243.4K
Total Short Term Compensation
486.6K
Total Value of Options
17.8M
Compensation as of Fiscal Year
Valbiotis SA CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Humanigen, Inc. Announces Executive Changes
November 16, 2017 10:03 PM ET
Novelion Therapeutics Inc. Announces Board Appointments
November 16, 2017 9:02 PM ET
Premier Biomedical Appoints Carl Eller as Marketing & Planning Vice-President
November 16, 2017 3:00 PM ET
Gt Biopharma, Inc. Appoints Shawn M. Cross as President and Chief Operating Officer
November 16, 2017 1:01 PM ET
Formycon AG Appoints Stefan Glombitza as COO
November 16, 2017 7:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Valbiotis SA, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.